4ly9: Difference between revisions

Revision as of 13:45, 20 November 2013

[GCKR_HUMAN] Inhibits glucokinase by forming an inactive complex with this enzyme.

4ly9 is a 2 chain structure. Full crystallographic information is available from OCA.

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
+{{STRUCTURE_4ly9|  PDB=4ly9  |  SCENE=  }}
+===Human GKRP complexed to AMG-1694 [(2R)-1,1,1-trifluoro-2-{4-[(2S)-2-{[(3S)-3-methylmorpholin-4-yl]methyl}-4-(thiophen-2-ylsulfonyl)piperazin-1-yl]phenyl}propan-2-ol] and sorbitol-6-phosphate===
-The entry 4ly9 is ON HOLD  until Paper Publication
+==Function==
+[[http://www.uniprot.org/uniprot/GCKR_HUMAN GCKR_HUMAN]] Inhibits glucokinase by forming an inactive complex with this enzyme.
-Authors: Jordan, S.R.
+==About this Structure==
+[[4ly9]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LY9 OCA].
-Description:
+[[Category: Jordan, S R.]]
+[[Category: Carbohydrate binding protein]]
+[[Category: Disruptor ligand complex]]
+[[Category: Gkrp binds to gk]]
+[[Category: Liver]]
+[[Category: Regulatory protein]]
+[[Category: Sis domain]]